News Report

————————————————————————————————————————————————————

20

/ Mar 2025

Santo Therapeutics Begins Clinical Trial Targeting NF2-Related Tumours

——————

Read More →

————————————————————————————————————————————————————

13

/ Mar 2025

Dr. Zhou Lu, CEO of Santo Therapeutics, Named to Observer’s Annual Scientific Innovation Figures List

——————

Read More →

————————————————————————————————————————————————————

25

/ Feb 2025

Subject Recruitment Now Open for NF2 Gene Mutation-Related Solid Tumors

——————

Read More →

————————————————————————————————————————————————————

<

1

>